Coronary interventions

Procedural microvascular activation in long lesions treated with bioresorbable vascular scaffolds or everolimus-eluting stents: the PROACTIVE trial

EuroIntervention 2020;16:e147-e154. DOI: 10.4244/EIJ-D-18-01138

Mariano Pellicano
Mariano Pellicano1,2, MD, PhD, MSc; Giuseppe Di Gioia1,2, MD; Giovanni Ciccarelli1, MD; Panagiotis Xaplanteris1, MD, PhD; Leen Delrue1, MD, PhD; Gabor G. Toth3, MD, PhD; Frederik Van Durme1, MD; Alex Heyse1, MD; Eric Wyffels1, MD; Marc Vanderheyden1, MD; Jozef Bartunek1, MD, PhD; Bernard De Bruyne1, MD, PhD; Emanuele Barbato1,2, MD, PhD
1. Cardiovascular Center Aalst, OLV Clinic, Aalst, Belgium; 2. Department of Advanced Biomedical Sciences, University Federico II, Naples, Italy; 3. University Heart Center Graz, Medical University of Graz, Graz, Austria

Aims: Significant platelet activation after long stented coronary segments has been associated with periprocedural microvascular impairment and myonecrosis. In long lesions treated either with an everolimus-eluting bioresorbable vascular scaffold (BVS) or an everolimus-eluting stent (EES), we aimed to investigate (a) procedure-related microvascular impairment, and (b) the relationship of platelet activation with microvascular function and related myonecrosis.

Methods and results: Patients (n=66) undergoing elective percutaneous coronary intervention (PCI) in long lesions were randomised 1:1 to either BVS or EES. The primary endpoint was the difference between groups in changes of pressure-derived corrected index of microvascular resistance (cIMR) after PCI. Periprocedural myonecrosis was assessed by high-sensitivity cardiac troponin T (hs-cTnT), platelet reactivity by high-sensitivity adenosine diphosphate (hs-ADP)-induced platelet reactivity with the Multiplate Analyzer. Post-dilatation was more frequent in the BVS group, with consequent longer procedure time. A significant difference was observed between the two groups in the primary endpoint of ΔcIMR (p=0.04). hs-ADP was not different between the groups at different time points. hs-cTnT significantly increased after PCI, without difference between the groups.

Conclusions: In long lesions, BVS implantation is associated with significant acute reduction in IMR as compared with EES, with no significant interaction with platelet reactivity or periprocedural myonecrosis.

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

drug-eluting stentbioresorbable scaffoldsfractional flow reservestable anginaother technique
Coronary interventionsStable CADStents and scaffolds
Read next article
Coronary vasomotor function and myocardial flow with bioresorbable vascular scaffolds or everolimus-eluting metallic stents: a randomised trial

Latest news